OXYCODONE AND ASPIRIN

Post-LOE

oxycodone and aspirin

Epic Pharma Llc

ANDAORALTABLET

Approved

Jul 2020

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

OXYCODONE AND ASPIRIN (oxycodone and aspirin) by Epic Pharma Llc is cyclooxygenase inhibitors [moa]. Approved for pain severe enough to require an opioid analgesic, for which alternative treatments are inadequate. First approved in 2020.

Drug data last refreshed 13h ago

Mechanism of Action

Cyclooxygenase Inhibitors

Pharmacologic Class:

Nonsteroidal Anti-inflammatory Drug

Indications (2)

pain severe enough to require an opioid analgesic for which alternative treatments are inadequate

Worked on OXYCODONE AND ASPIRIN at Epic Pharma Llc? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.